Status: Recruiting
Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors
This interventional study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of SYN818 with Olaparib in adult patients with locally advanced or metastatic solid tumors
Participants needed: 110
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdUpdated: Sep 5, 2025Locations: 2
Eligibility criteria
Having signed the written Informed Consent Form (ICF); [+8]
Previous or current use of DNA Polymerase Theta (POLQ) inhibitors; [+7]